新興
BiPAP A40 EFL Ventilator The first BiPAP Noninvasive COPD ventilator

BiPAP A40 EFL Ventilator

The first BiPAP Noninvasive COPD ventilator

尋找類似產品

While the majority of COPD patients have EFL, care teams have never had a COPD NIV ventilation therapy that dynamically and automatically targets EFL. BiPAP A40 EFL is the first and only NIV therapy precision-crafted to abolish EFL in hypercapnic COPD patients. It screens, detects and auto-optimizes pressure – to treat comfortably and redefine what is possible in managing COPD.

  • 1. Dellaca, R. L., Santus, P., Aliverti, A., Stevenson, N., Centanni, S., Macklem, P. T. & Calverley, P. M. A. (2004). Detection of expiratory flow limitation in COPD using the forced oscillation technique. European Respiratory Journal, 23(2), 232-240.
  • 2. Aarli, B. B., Calverley, P. M., Jensen, R. L., Dellacà, R., Eagan, T. M., Bakke, P. S., & Hardie, J. A. (2017). The association of tidal EFL with exercise performance, exacerbations, and death in COPD. International journal of chronic obstructive pulmonary disease, 12, 2179 † COPD patients with a DeltaXrs ≥ upper normal limit (ULN)
  • 3. ES Suh1, P. P. (2014). Abolition of expiratory flow limitation in severe COPD using auto-titrating CPAP based on the measurement of within-breath airway reactance determined by the forced oscillation technique. †† Context: Stable and Ventilated Hypercapnic COPD patients
  • 4. Key ventilation parameters, alarm data, device performance and patient usag